Extension of strategic alliance with Summit

Summit Therapeutics and Oxford have announced a multi-year extension of their strategic alliance for the development of utrophin modulators to treat Duchenne Muscular Dystrophy.

Read more

Spinout Perspectum secures FDA clearance, closes $5m round

Perspectum announced today it has been given US FDA clearance to market its test for diagnosing and measuring liver disease.

Read more

Spinout OrganOx gets European regulatory approval

Oxford University Innovation spinout OrganOx has received CE mark certification for its OrganOx metra device, which improves the success of liver transplantation.

Read more

Oxford spin-out to use phase change materials for smart glazing, displays

Read more

An innovation community: Oxford

Outside London, it is arguable that no other region has had more of an effect on the evolution of the UK than Oxford. From custodians of the English language to leaders of the country, Oxford has continued to have a major impact on the shape and destiny of the British people.

Read more

Spinout First Light Fusion raises £22.7m

First Light Fusion, spun out from the University of Oxford with help from Oxford University Innovation, has raised £22.7m million to develop process for achieving practical and affordable fusion energy.

Read more